Technology
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup
July 15, 2026 at 05:27 AM
OpenAI researcher Miles Wang is leaving the company to launch a startup focused on AI models for drug discovery, with talks to raise $200 million at a $2 billion valuation.
- Wang is leaving OpenAI to launch a startup focused on developing AI models for drug discovery.
- He is in talks to raise about $200 million at a $2 billion valuation, with Lightspeed in discussions to lead the round; talks are ongoing and may not finalize.
- Wang disputed the reported funding figures and description of the company but did not provide correct details.
- Several other OpenAI researchers are expected to join the new company.